Free Trial Information
BioCentury | Feb 9, 2009
Finance

Ebb & Flow

...led by the company's largest investor, Essex Woodlands Health Ventures, and included LD Pension Fund; Scandinavian Life Science Venture...
Read More
BioCentury | Feb 5, 2009
Financial News

Symphogen raises EUR 33 million

...a Series E round led by existing investor Essex Woodlands Health Ventures. LD Pension Fund; Scandinavian Life Science Venture...
Read More
BioCentury | May 26, 2008
Finance

Ebb & Flow

...series A round, bringing that round's total to $67 million. Existing investors include Essex Woodlands; Scandinavian Life Science Venture...
Read More
BioCentury | Dec 17, 2007
Emerging Company Profile

Corporate Profile

...Corporate partners: None Number of employees: 30 Funds raised: SEK339 million ($46.7 million) Investors: HealthCap, Scandinavian Life Science Venture...
Read More
BioCentury | Oct 22, 2007
Strategy

One deal at a time

...will receive another SEK171 million ($26.4 million) capital contribution this year from Biolipox shareholders, including Scandinavian Life Science Venture...
Read More
BioCentury | Sep 24, 2007
Company News

Elan board of directors update

Elan Corp. plc (ELN), Dublin, Ireland Business: Drug delivery, Neurology, Autoimmune Appointed: Jonas Frick, former CEO of Scandinavian Life Science Ventures; and Giles Kerr, director of finance at the University of Oxford WIR Staff autoimmune...
Read More
BioCentury | Jul 3, 2007
Financial News

OxThera raises $21.8 million

...$21.9 million) in a series B round led by new investor Industrifonden. Existing investors HealthCap; Scandinavian Life Science Venture...
Read More
BioCentury | May 1, 2006
Finance

Ebb & Flow

...with $57.3 million in cash. Principal stockholders include Essex Woodlands (18.9% prior to the IPO); Scandinavian Life Science Venture...
Read More
BioCentury | Jan 10, 2006
Financial News

Symphogen raises $25 million

...in a series D round. Investors included Takeda ; LD Pensions; Essex Woodlands Health Ventures; Scandinavian Life Science Venture...
Read More
BioCentury | Dec 15, 2005
Financial News

Light Sciences Oncology raises $32 million

...Ventures, which led the first closing in October, participated in the second closing, along with Scandinavian Life Science Venture...
Read More
Items per page:
1 - 10 of 29
BioCentury | Feb 9, 2009
Finance

Ebb & Flow

...led by the company's largest investor, Essex Woodlands Health Ventures, and included LD Pension Fund; Scandinavian Life Science Venture...
Read More
BioCentury | Feb 5, 2009
Financial News

Symphogen raises EUR 33 million

...a Series E round led by existing investor Essex Woodlands Health Ventures. LD Pension Fund; Scandinavian Life Science Venture...
Read More
BioCentury | May 26, 2008
Finance

Ebb & Flow

...series A round, bringing that round's total to $67 million. Existing investors include Essex Woodlands; Scandinavian Life Science Venture...
Read More
BioCentury | Dec 17, 2007
Emerging Company Profile

Corporate Profile

...Corporate partners: None Number of employees: 30 Funds raised: SEK339 million ($46.7 million) Investors: HealthCap, Scandinavian Life Science Venture...
Read More
BioCentury | Oct 22, 2007
Strategy

One deal at a time

...will receive another SEK171 million ($26.4 million) capital contribution this year from Biolipox shareholders, including Scandinavian Life Science Venture...
Read More
BioCentury | Sep 24, 2007
Company News

Elan board of directors update

Elan Corp. plc (ELN), Dublin, Ireland Business: Drug delivery, Neurology, Autoimmune Appointed: Jonas Frick, former CEO of Scandinavian Life Science Ventures; and Giles Kerr, director of finance at the University of Oxford WIR Staff autoimmune...
Read More
BioCentury | Jul 3, 2007
Financial News

OxThera raises $21.8 million

...$21.9 million) in a series B round led by new investor Industrifonden. Existing investors HealthCap; Scandinavian Life Science Venture...
Read More
BioCentury | May 1, 2006
Finance

Ebb & Flow

...with $57.3 million in cash. Principal stockholders include Essex Woodlands (18.9% prior to the IPO); Scandinavian Life Science Venture...
Read More
BioCentury | Jan 10, 2006
Financial News

Symphogen raises $25 million

...in a series D round. Investors included Takeda ; LD Pensions; Essex Woodlands Health Ventures; Scandinavian Life Science Venture...
Read More
BioCentury | Dec 15, 2005
Financial News

Light Sciences Oncology raises $32 million

...Ventures, which led the first closing in October, participated in the second closing, along with Scandinavian Life Science Venture...
Read More
Items per page:
1 - 10 of 29